Skip to content

Author

Su-Ping Gu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A randomised controlled study of canagliflozin in improving diabetic kidney disease through a podocyte protection mechanism.

Introduction This study aimed to investigate whether canagliflozin improves diabetic kidney disease (DKD) through a podocyte protective mechanism. Method DKD patients were randomly assigned to the experimental group (87 patients: standard therapy plus cangliflozin 100 mg/day) and the control group (85 patients: stand...

Su-Ping Gu, Na Zhu, Guo-Juan Hang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.